Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Item
http://www.wikidata.org/entity/Q43726131
Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.Ongoing trials of immune-based therapies for HIV infection in adults.Development of immunotherapeutic strategies for HIV-1.Current progress in the development of a prophylactic vaccine for HIV-1.Prospects for immune reconstitution in HIV-1 infection.Immunotherapy with an HIV-DNA Vaccine in Children and Adults.Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression.Clinical experience with therapeutic AIDS vaccines.Therapeutic immunization strategies for the control of HIV-1.Loss of circulating CD4 T cells with B cell helper function during chronic HIV infectionTherapeutic vaccines against HIV infection.Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes
P2860

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Item
http://www.wikidata.org/entity/Q43726131
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Efficacy testing of recombinan ...... hase II Vaccine Investigators.
@en
Efficacy testing of recombinant human immunodeficiency virus
@nl
type
label
Efficacy testing of recombinan ...... hase II Vaccine Investigators.
@en
Efficacy testing of recombinant human immunodeficiency virus
@nl
prefLabel
Efficacy testing of recombinan ...... hase II Vaccine Investigators.
@en
Efficacy testing of recombinant human immunodeficiency virus
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Efficacy testing of recombinan ...... Phase II Vaccine Investigators
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921